195 related articles for article (PubMed ID: 16939704)
1. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Kuo YC; Chen HH
Int J Pharm; 2006 Dec; 327(1-2):160-9. PubMed ID: 16939704
[TBL] [Abstract][Full Text] [Related]
2. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
3. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
4. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
5. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells.
Kuo YC; Chung CY
Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614
[TBL] [Abstract][Full Text] [Related]
6. Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles.
Kuo YC
Int J Pharm; 2005 Feb; 290(1-2):161-72. PubMed ID: 15664142
[TBL] [Abstract][Full Text] [Related]
7. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.
Gil ES; Li J; Xiao H; Lowe TL
Biomacromolecules; 2009 Mar; 10(3):505-16. PubMed ID: 19216528
[TBL] [Abstract][Full Text] [Related]
8. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
9. Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat.
Wu D; Clement JG; Pardridge WM
Brain Res; 1998 Apr; 791(1-2):313-6. PubMed ID: 9593963
[TBL] [Abstract][Full Text] [Related]
10. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
11. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
12. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
Jallouli Y; Paillard A; Chang J; Sevin E; Betbeder D
Int J Pharm; 2007 Nov; 344(1-2):103-9. PubMed ID: 17651930
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of zidovudine and lamivudine from rat tissues by liquid chromatography/tandem mass spectrometry.
Alnouti Y; Lewis SR; White CA; Bartlett MG
Rapid Commun Mass Spectrom; 2005; 19(4):503-8. PubMed ID: 15678520
[TBL] [Abstract][Full Text] [Related]
14. Effect of transport inhibitors and additional anti-HIV drugs on the movement of lamivudine (3TC) across the guinea pig brain barriers.
Gibbs JE; Rashid T; Thomas SA
J Pharmacol Exp Ther; 2003 Sep; 306(3):1035-41. PubMed ID: 12766261
[TBL] [Abstract][Full Text] [Related]
15. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
[TBL] [Abstract][Full Text] [Related]
16. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
Kayitare E; Vervaet C; Ntawukulilyayo JD; Seminega B; Bortel V; Remon JP
Int J Pharm; 2009 Mar; 370(1-2):41-6. PubMed ID: 19059324
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH
Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946
[TBL] [Abstract][Full Text] [Related]
18. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Gao K; Jiang X
Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
[TBL] [Abstract][Full Text] [Related]
19. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
20. β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier.
Gil ES; Wu L; Xu L; Lowe TL
Biomacromolecules; 2012 Nov; 13(11):3533-41. PubMed ID: 23066958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
